Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christine Stephan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Operative Orthopadie Und Traumatologie|January 9, 2010
[Dorsal capsulodesis for the treatment of scapholunate instability]Christine Stephan, Karl-Josef Prommersberger, Jörg van Schoonhoven
Plos One|November 25, 2020
Experiencing social connection: A qualitative study of mothers of nonspeaking autistic childrenVikram K Jaswal, Janette Dinishak, Christine Stephan, et al.
Operative Orthopadie Und Traumatologie|March 14, 2008
[Acute flexor tendon surgery]Christine Stephan, Ali Saalabian, Jörg van Schoonhoven, et al.
Molecular Cancer Therapeutics|April 18, 2009
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibitionMadlaina Breuleux, Matthieu Klopfenstein, Christine Stephan, et al.
Cancer Research|May 17, 2008
The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancerAnne Boulay, Madlaina Breuleux, Christine Stephan, et al.
Cancer Research|January 20, 2004
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cellsAnne Boulay, Sabine Zumstein-Mecker, Christine Stephan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic dataChiaki Tanaka, Terence O'Reilly, John M Kovarik, et al.
Cancer Research|July 20, 2007
The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cellsNagako Akeno-Stuart, Michelle Croyle, Jeffrey A Knauf, et al.
Cell|December 10, 2024
Dual BACH1 regulation by complementary SCF-type E3 ligasesBenedikt Goretzki, Maryam Khoshouei, Martin Schröder, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Operative Orthopadie Und Traumatologie|January 9, 2010
[Dorsal capsulodesis for the treatment of scapholunate instability]Christine Stephan, Karl-Josef Prommersberger, Jörg van Schoonhoven
Plos One|November 25, 2020
Experiencing social connection: A qualitative study of mothers of nonspeaking autistic childrenVikram K Jaswal, Janette Dinishak, Christine Stephan, et al.
Operative Orthopadie Und Traumatologie|March 14, 2008
[Acute flexor tendon surgery]Christine Stephan, Ali Saalabian, Jörg van Schoonhoven, et al.
Molecular Cancer Therapeutics|April 18, 2009
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibitionMadlaina Breuleux, Matthieu Klopfenstein, Christine Stephan, et al.
Cancer Research|May 17, 2008
The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancerAnne Boulay, Madlaina Breuleux, Christine Stephan, et al.
Cancer Research|January 20, 2004
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cellsAnne Boulay, Sabine Zumstein-Mecker, Christine Stephan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Identifying optimal biologic doses of everolimus (RAD001) in patients with cancer based on the modeling of preclinical and clinical pharmacokinetic and pharmacodynamic dataChiaki Tanaka, Terence O'Reilly, John M Kovarik, et al.
Cancer Research|July 20, 2007
The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cellsNagako Akeno-Stuart, Michelle Croyle, Jeffrey A Knauf, et al.
Cell|December 10, 2024
Dual BACH1 regulation by complementary SCF-type E3 ligasesBenedikt Goretzki, Maryam Khoshouei, Martin Schröder, et al.
Blood Cancer Journal|July 19, 2022
BRD9 degraders as chemosensitizers in acute leukemia and multiple myelomaEllen Weisberg, Basudev Chowdhury, Chengcheng Meng, et al.
Pageof 2